Cyclopharm Limited (ASX:CYC)
0.4750
+0.0350 (7.95%)
Nov 20, 2026, 4:10 PM AEDT
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 59.72 million as of November 20, 2026. It is the 31,219th most valuable company in the world and the 709th biggest in Australia. Its market cap has decreased by 28.35% in one year.
Market Cap
59.72M
Enterprise Value
55.28M
Revenue
34.42M
Global Rank
Country Rank
#709 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 59.72M, an increase of 17.35%. That is a compound annual growth rate of 0.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 59.72M | -45.16% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EBR Systems | 131.05M |
| Lumos Diagnostics Holdings | 69.96M |
| SomnoMed | 68.13M |
| Epiminder | 59.58M |
| Saluda Medical | 49.14M |
| Compumedics | 46.94M |
| Nova Eye Medical | 45.59M |
| HeraMED | 40.55M |